Clinical and Prognostic Significance of ANCCA in Squamous Cell Lung Carcinoma Patients

详细信息    查看全文

• 作者：Dingmiao Wang^a ; ^b ; Yang Pan^a ; Ting Hao^a ; Yong Chen^a ; Shiming Qiu^a ; Ling Chen^a ; Jinping Zhao^b ; ^{zhaojinping136@126.com" class="auth_mail" title="E-mail the corresponding author} ; ^{jpzhao@tjh.tjmu.edu.cn" class="auth_mail" title="E-mail the corresponding author}
• 关键词：ANCCA ; Lung squamous cell carcinoma ; Biomarker ; Prognosis
• 刊名：Archives of Medical Research
• 出版年：2016
• 出版时间：February 2016
• 年：2016
• 卷：47
• 期：2
• 页码：89-95
• 全文大小：953 K

文摘

AAA+ nuclear coregulatory cancer associated (ANCCA) has been demonstrated as playing important roles in diverse biological processes including tumorigenesis. However, the clinical and prognostic significance of ANCCA in squamous cell lung carcinoma (SCLC) patients is still unknown. The aim of this study is to identify the role of ANCCA in SCLC patients.

Methods

ANCCA mRNA and protein expressions were detected in SCLC tissues and cell lines by real-time PCR and Western blot. We examined the ANCCA protein expression in 152 SCLC samples by immunohistochemistry and analyzed the association between the expression of ANCCA protein and clinicopathological characteristics of SCLC patients.

Results

ANCCA mRNA and protein expression are increased in SCLC tissues and cell lines. Moreover, ANCCA protein overexpression was associated with differentiated degree, clinical stage, lymph node metastasis, and distant metastasis. In uni- and multivariate analyses, ANCCA protein overexpression was an independent poor prognostic factor for SCLC patients.

Conclusions

ANCCA act as a potential biomarker for therapeutic strategy and prognostic prediction for SCLC.